D
Rhythm Pharmaceuticals, Inc. RYTM
$50.97 $0.731.45%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 130.13M 112.53M 101.78M 91.93M 77.43M
Total Other Revenue -- -- -- -- --
Total Revenue 130.13M 112.53M 101.78M 91.93M 77.43M
Cost of Revenue 13.37M 12.82M 11.40M 10.69M 9.30M
Gross Profit 116.76M 99.72M 90.38M 81.24M 68.13M
SG&A Expenses 144.30M 138.55M 133.65M 127.28M 117.53M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 395.63M 378.05M 367.37M 363.64M 261.78M
Operating Income -265.51M -265.52M -265.58M -271.71M -184.35M
Income Before Tax -260.22M -258.28M -258.09M -273.01M -184.11M
Income Tax Expenses 345.00K 631.00K 1.34M 864.00K 564.00K
Earnings from Continuing Operations -260.57 -258.91 -259.43 -273.87 -184.68
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -260.57M -258.91M -259.43M -273.87M -184.68M
EBIT -265.51M -265.52M -265.58M -271.71M -184.35M
EBITDA -263.94M -263.92M -263.93M -270.00M -182.60M
EPS Basic -4.36 -4.34 -4.37 -4.64 -3.21
Normalized Basic EPS -2.68 -2.68 -2.70 -2.89 -2.00
EPS Diluted -4.36 -4.34 -4.37 -4.64 -3.21
Normalized Diluted EPS -2.68 -2.68 -2.70 -2.89 -2.00
Average Basic Shares Outstanding 243.97M 241.59M 238.24M 234.10M 230.66M
Average Diluted Shares Outstanding 243.97M 241.59M 238.24M 234.10M 230.66M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings